PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30998852 ↗2019Reported benefit

-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

MouseIschaemia-reperfusionCardiacC57BL/6Jmalen = 73 mice with myocardial infarction in protocol 1 (vehicle n…intraperitoneal continuous infusion by ALZET osmotic minipump1.6 mg/kg per dayminipump implanted 7 days before myocardial infarction in the acute rupture pro…

Model: Myocardial infarction by permanent ligation of the left anterior descending coronary artery

Cardiac rupture at 7 days fell from 60.5% in vehicle-treated to 23.3% in Ac-SDKP-treated mice, with reduced ICAM-1, macrophage infiltration, gelatinolytic activity, p53 and cardiomyocyte apoptosis, and increased capillary density in the infarct border, without change in infarct size. At 5 weeks Ac-…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.88. Machine-extracted fields require source verification.